versus
No demonstrated result for efficacy
pulmonary embolims (symptomatic and asymptomatic) 0.22 [0.05; 0.93]
death 1.00 [0.29; 3.40]
major bleeding 1.50 [0.54; 4.14]
asymptomatic pulmonary embolism 0.00 [0.00; NaN]
symptomatic pulmonary embolism 0.40 [0.08; 2.04]
caval filter (n=200)
vs.
no filter (n=200)
2x2 factorial design also comparing LMWH vs unfractionated heparin
open
Parallel groups
Sample size: 200/200
Primary endpoint: none
FU duration: 12 days and 2 years